Overweight Trials in chapel hill, united states
Conditions / Overweight / chapel hill, united states
31 total trials for this combination
Showing top 10 of 31 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03574597 | Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity | COMPLETED | PHASE3 |
| NCT06962280 | A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT07392190 | A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin | RECRUITING | PHASE3 |
| NCT06993792 | A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes | RECRUITING | PHASE3 |
| NCT03552757 | Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity | COMPLETED | PHASE3 |
| NCT04705779 | The HARMONY Study: A Intervention to Reduce Cardiometabolic Risk in African American Women | COMPLETED | NA |
| NCT04184622 | A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight | COMPLETED | PHASE3 |
| NCT05803421 | A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04657003 | A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight | COMPLETED | PHASE3 |
| NCT06972472 | A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes | RECRUITING | PHASE3 |